Tag

birth defects Archives - Carey Danis & Lowe

Another Win for Topamax Birth Defect Victims

By | Pharmaceutical litigation, Topamax, Uncategorized

topamax-lawsuit-settlementsDrug companies manage to find a way to appeal a case. However, in a Topamax birth defect suit, the court found that there was no reason to reconsider the earlier decision affirming a $4.2 million award.

The lawsuit involves the plaintiff, April Czimmer against Janssen Pharmaceuticals. Ms. Czimmer was awarded the large verdict because the jury found that the drug maker failed to sufficiently warn doctors about the extent of the risk of birth defects developing from the use of Topamax. The jury charged that the company’s negligence was a significant factor in causing April Czimmer son’s cleft palate.

The appeal hinged on the words “substantial contributing factor”, with the pharmaceutical company saying that the phrase was vague and confusing for the jurors. However, the Pennsylvania Superior Court denied the company’s effort to reconsider the 4.2 million verdict because jury instructions followed the precedent and were clear in defining the phrase.

This is excellent news for Czimmer and her son―and for families across the US who’ve been impacted by Topamax birth defects.

CD&L can help victims of birth defects caused by Topamax.

Our Topamax lawyers are currently investigating cases involving women who took Topamax during their pregnancy, and had infants with birth defects, especially cleft lips and cleft palates.

We offer free case evaluations, during which one of our lawyers will guide you through compensation eligibility, legal options, and whether filing a Topamax birth defect lawsuit is right for you.

Please call us at 800.721.2519 to discuss how we can help you get the justice you deserve.

Zofran Birth Defect Lawsuit Filed in Ohio

By | Pharmaceutical litigation, Uncategorized, Zofran

zofran-birth-defectsA mother suffered severe nausea during her pregnancy. She listened to her doctor’s recommendation to take Zofran, an anti-nausea drug that doctors sometimes prescribe off-label to treat morning sickness.

The mother took Zofran during her pregnancy, and she delivered a child with birth defects.

The suffering and emotional strain resulting from the child’s birth defects led the mother to file a Zofran birth defect lawsuit targeting the drug’s manufacturer, GlaxoSmithKline (GSK).

The family filed the lawsuit in July 2015 in the US District Court for the Northern District of Ohio, Eastern Division.

The child suffered from a cleft lip, cleft palate, speech impediments, and ear problems. As a result of these birth defects, the child underwent 8 reparative surgeries. According to the child’s doctors, they expect to perform future surgical operations.

This is no way for a child to grow up.

GSK must be held accountable for pushing Zofran on physicians and pregnant mothers.

According to this lawsuit’s court filing, GSK didn’t conduct studies on Zofran use during pregnancy. Instead, the pharmaceutical giant went straight to promoting the drug as safe for pregnancy. The court document states that “GSK’s conduct was tantamount to using expectant mothers and their unborn children as human guinea pigs.”

In pushing the off-label prescription of Zofran for morning sickness, GSK thought only of sales, and not at all of consumer safety.

We are here for you.

The Zofran lawyers at Carey Danis & Lowe can help you and your family. If you used Zofran during your pregnancy, and your child developed birth defects in the womb, we encourage you to explore your legal options today.

Our Zofran lawyers are currently investigating birth defect cases, and are offering free case evaluations. We can help you decide if filing a lawsuit is the right decision for you and your family.

Contact Carey Danis & Lowe today.

You can reach us by phone at 800.721.2519, or by completing a confidential personal injury claim form.

Zofran Litigation: Drug Caused Cleft Palate say Mississippi Parents

By | Pharmaceutical litigation, Uncategorized, Zofran

zofran-birth-defectsNew lawsuits allege that the anti-nausea drug, Zofran is to blame for cleft palate in infants whose mothers took the drug at the beginning of pregnancies.

One Mississippi family claims that exposure to Zofran during the first trimester caused their daughter’s soft cleft palate. The lawsuits, filed against drug behemoth GlaxoSmithKline, were issued in the US District Court for the Southern District of Mississippi on July 17, 2015. It’s believed that they are the first parents to file in the Mississippi Federal Court.

In January 2015, the Mississippi mother gave birth to a child diagnosed with soft cleft palate. With this disability, the roof of the mouth is split, which affects feeding, speech, breathing and language development. There’s no history of birth defects in this family and a previous child was born healthy and without congenital problems.

Are there links between Zofran and Cleft Palate?

While the drug is prescribed as an “off label” treatment for morning sickness, its efficacy hasn’t been proven and recent research has found a link between the drug and birth defects.

A paper published by researchers at Harvard and Boston University, discovered a 2.37 times increase in the chance for cleft palate after prenatal exposure to Zofran.

While 34 families have filed Zofran lawsuits in Federal Court, that number hardly compares to the amount of women who have been exposed to the pharmaceutical during pregnancy. Zofran use has soared to over 1 million prescriptions every year.

Carey Danis & Lowe can help with Zofran Birth Defect Lawsuits

If you or someone you love used Zofran during the first trimester of pregnancy, and a child was born with birth defects, then you or your loved one may be eligible to receive compensation.

Contact Carey Danis & Lowe for a free legal consultation. One of our Zofran lawyers will walk you through your litigation options, and whether filing a Zofran birth defect lawsuit is the right path for you.

Call Carey Danis & Lowe at 800.721.2519, or complete a confidential personal injury claim form.

New Study: Celexa & Zoloft Disrupt Unborn Baby Bone Growth

By | Pharmaceutical litigation, Uncategorized, Zoloft

topamax_birth_defects_topamax_lawsuit_settlementsCelexa and Zoloft, two drugs used to treat depression, are linked to many types of birth defects. And according to a recently published study, these two antidepressants are now linked to poor bone development.

The study, Citalopram and sertraline exposure compromises embryonic bone development, appeared in Molecular Psychiatry in September 2015.

The researchers looked at bone development in zebrafish embryos and human adult stem cells.

In both cases, they discovered that exposure to either Celexa (citalopram) or Zoloft (sertraline) resulted in inhibited bone growth.

In concluding their findings, the researchers emphasized that, “[t]hese results highlight the need to further investigate the risks of SSRI use during pregnancy in exposing unborn babies to potential skeletal abnormalities.”

WE CAN HELP YOU

Do you have questions about use of antidepressants like Celexa and Zoloft during pregnancy?

If so, contact the law offices of Carey Danis & Lowe. Our team includes experienced trial attorneys and medical professionals, who are both available to answer your questions and discuss your concerns.

If you used a selective serotonin reuptake inhibitor (SSRI) antidepressant, such as Celexa or Zoloft, during your pregnancy, and your child was born with birth defects, we encourage you to contact one of our SSRI birth defect lawyers today.

We offer free case evaluations, and can help you decide whether filing a Celexa or Zoloft birth defect lawsuit is right for you and your family.

Contact Carey Danis & Lowe today.

You can reach us by phone at 800.721.2519, or by completing a confidential personal injury claim form.

 

 

Appeals Court Upholds $4M Topamax Birth Defect Lawsuit Verdict

By | Pharmaceutical litigation, Topamax, Uncategorized

topamax-lawsuit-settlementsA pharmaceutical giant will go to the ends of the earth to find a way to appeal a case. However, in the Topamax birth defect lawsuit involving plaintiff, April Czimmer, the maker of Topamax presented an appeal that didn’t hold together in court. A panel of judges in a Pennsylvania appeals court struck down Johnson & Johnson’s appeal in late August 2015.

The drug maker originally questioned the October 2013 jury verdict, which ordered Johnson & Johnson to pay the plaintiff $4 million. They argued that the jury verdict and the jury’s explanation didn’t conform to a Virginia Supreme Court ruling about the specificity of language used when describing how a drug directly causes an injury.

In the Czimmer case, that injury was a birth defect of the plaintiff’s son known as a cleft palate caused by Topamax exposure in the womb.

The panel of judges agreed with the jury’s instructions, and that the jury’s explanation did demonstrate the causal relationship between Topamax and birth defects. According to a Law360 article about the appeals court decision, the “three-judge panel found that jury instructions in the case were not at odds with a Virginia Supreme Court ruling”.

The decision to uphold the $4 million verdict is excellent news for Czimmer and her son―and for families across the US who’ve been affected by Topamax birth defects.

We can help you.

Our Topamax lawyers are currently investigating cases involving women who consumed Topamax during their pregnancy, and had children with birth defects, especially cleft lips and cleft palates. We offer free case evaluations, during which one of our Topamax lawyers guides you through your legal options, compensation eligibility, and whether filing a Topamax birth defect lawsuit is right for you and your family.

Contact Carey Danis & Lowe for your free case consultation today. You can reach our law offices by phone at 800.721.2519. You can also share your Topamax story with us online by visiting https://www.careydanis.com/contact/, and completing your confidential personal injury claim form.

We look forward to offering you any assistance that we can.

Zofran Birth Defect Lawsuits: Carey Danis & Lowe Investigating Cases

By | Pharmaceutical litigation, Uncategorized, Zofran

zofranCarey Danis & Lowe is currently investigating Zofran birth defect cases, and is assisting families with filing Zofran birth defect lawsuits.

Zofran is an anti-nausea drug manufactured by GlaxoSmithKline, and was originally intended to prevent nausea and vomiting in patients undergoing chemotherapy.

Ondansetron, the active ingredient in Zofran, has been linked to birth defects in children.

Swedish Study

A Swedish study, published in Reproductive Toxicology in December 2014, found that children exposed to Zofran in the womb had double the risk of developing a heart defect. The researchers also discovered that the most common heart defect was a hole in the heart, also known as an atrial or ventricular septal defect.

BioMed Study

Another study published in 2013 by BioMed Research International found a 20% increased risk of children developing major birth defects if exposed to Zofran in the first trimester of pregnancy. Still, the researchers noted that they could not make a firm determination on the safety of Zofran for pregnant women based on their results.

LeClair Zofran Birth Defect Lawsuit

Tomisha LeClair filed a Zofran birth defect lawsuit after her child was born with an atrial septal defect, among many other birth defects that included facial dysmorphia and hearing loss.

LeClair claimed that her child’s birth defects resulted from exposure to Zofran in the womb.

Many women like LeClair, along with their families, have filed lawsuits against GlaxoSmithKline. These lawsuits assert that the pharmaceutical giant marketed Zofran to pregnant women, and made the anti-nausea drug appear to be safe to use.

However, as these women discovered, Zofran is not safe for pregnant mothers and their unborn children.

You are not alone. You don’t have to suffer in silence.

The team of experienced Zofran lawyers at Carey Danis & Lowe work to recover losses for people like you. Contact our law firm for a free case evaluation. One of our Zofran lawyers can guide you through your legal options, and whether filing a Zofran birth defect lawsuit is right for you.

You can reach our law firm by phone at 800.721.2519, or by completing a confidential personal injury claim form.

Twelve Families File Lexapro Birth Defects Lawsuits

By | Lexapro, Pharmaceutical litigation, Uncategorized

SSRI Antidepressant Lexapro Birth Defect LawsuitThe lives of twelve families have been permanently impacted by Lexapro, an antidepressant drug. These 12 families took their cases to court by filing individual Lexapro birth defects lawsuits targeting the drug’s manufacturer, Forest Pharmaceuticals, who also makes Celexa.

The children in these lawsuits were born with congenital birth defects, including heart defects. The families claim that the birth defects suffered by the children are the result of Lexapro exposure in the womb.

The families filed 12 Lexapro lawsuits in Cabell County Circuit Court in West Virginia.

They claim that Forest knew about the Lexapro birth defects risk from multiple studies. They allege that the pharmaceutical company still decided to market the drug to pregnant women and women who could become pregnant.

Furthermore, these families assert that Forest made no effort to update the Lexapro drug label with a warning about the birth defects risk.

According to the West Virginia Record, the families are seeking compensatory and punitive damages.

You are not alone.

If you used Lexapro during your pregnancy, and your child was born with birth defects, Carey Danis & Lowe is here to help. We want you to know that you are not alone. We can help answer your legal and medical questions.

We have a team of experienced trial attorneys who work tirelessly to recover losses for families like yours. One of our lawyers is available to discuss your Lexapro case during a free case evaluation. We can guide you through your legal options, and whether filing a Lexapro birth defects lawsuit is right for you.

The team at Carey Danis & Lowe also includes medical professionals. You can speak with one of our nurses, who can answer your questions about Lexapro, pregnancy, and certain kinds of birth defects.

Contact Carey Danis & Lowe today by phone at 800.721.2519, or by completing a confidential personal injury claim form.

We look forward to offering you any assistance that we can.

New Study Links Prozac & Paxil with Birth Defects

By | Paxil, Pharmaceutical litigation, Prozac, Uncategorized

ssri_birth_defectsA study published in the British Medical Journal links certain antidepressants with birth defects when used by pregnant women. The National Center on Birth Defects and Developmental Disabilities in Atlanta led the study.

Researchers looked at selective serotonin reuptake inhibitors, a class of antidepressants often referred to as SSRIs. The SSRIs included in the study were Paxil, Prozac, Celexa, Lexapro, and Zoloft.

The researchers recorded an increase in birth defects in children whose mothers used Prozac or Paxil early in their pregnancy. They reviewed 28,000 pregnancies between 1997 and 2009.

When women used Paxil one month before or during their first trimester, the risk of birth defects increased. For anencephaly, or a deformation of the skull, the risk rose from 2 per 10,000 to 7 per 10,000. For heart defects, the risk rose from 10 per 10,000 to 24 per 10,000.

In their study, the researchers emphasized that the Prozac and Paxil birth defects risk is small, but their findings do show a link. In light of this link, they called for further studies into the use of SSRI antidepressants in pregnant women.

It is highly recommended to speak with an obstetrician and mental health professional in order to make an informed decision about using SSRI antidepressants during pregnancy.

You are not alone.

At Carey Danis & Lowe, we understand the pain and suffering caused by birth defects. That’s why our team of experienced attorneys works tirelessly to recover losses for families impacted by Prozac birth defects or Paxil birth defects.

Interested in exploring your legal options?

Contact Carey Danis & Lowe today. We offer free case evaluations, during which we discuss your case, your compensation eligibility, and whether filing a Prozac or Paxil birth defects lawsuit is right for you.

You can reach our St. Louis law firm by phone at 800.721.2519, or by completing a confidential personal injury claim form.

We look forward to hearing from you, and offering you any assistance that we can.

J&J to Appeal $3M Verdict in Topamax Birth Defects Lawsuit

By | Pharmaceutical litigation, Topamax, Uncategorized

topamax_lawsuitIn March 2015, a Pennsylvania jury awarded a Wisconsin family a $3 million award in a Topamax birth defects lawsuit. The suit, which the family filed in December 2011, alleged that Johnson & Johnson, and the subsidiary Janssen Pharmaceuticals, failed to warn patients and health care providers about the birth defects risks associated with using Topamax while pregnant.

The family presented their case in the Philadelphia County Court of Common Pleas. The mother used Topamax during her pregnancy to treat chronic migraines. The family’s child was born with a cleft lip, which they claim is the result of the child’s exposure to Topamax in the womb.

According to a Law360 article on the Topamax lawsuit, about 3.8% of children exposed to Topamax in the womb develop an oral birth defect. Unfortunately, the risk of developing a cleft lip or a cleft palate is high for these children.

Johnson & Johnson and Janssen Pharmaceuticals expressed empathy for the family in the case. However, the defendants said that they made the decision to appeal the jury’s $3 million verdict.

They felt that the jury didn’t account for other factors that may have influenced the child’s development of a cleft lip.

We are here to help you.

Carey Danis & Lowe works with families whose children have been injured by Topamax in the womb. Our team of defective drug lawyers is dedicated to recovering losses for these families.

Our lawyers are available to help you. We offer free case evaluations, during which we discuss your case, your compensation eligibility, and whether filing a Topamax birth defects lawsuit is right for you and your family.

The Carey Danis & Lowe staff also includes medical professionals, who are available to answer your questions about Topamax birth defects.

You can reach our law offices by phone at 800.721.2519, or by completing a confidential personal injury claim form.

We look forward to offering you any assistance that we can.

Continue to read the Carey Danis & Lowe blog for Topamax lawsuit updates. You may be interested in reading:

First Zoloft Birth Defects Lawsuit to Go to Trial: What Pfizer Knew

By | Pharmaceutical litigation, Uncategorized, Zoloft

Zoloft MDL Updates: Zoloft MDL No. 2342 Progresses with Order to Submit Initial Discovery Zoloft Birth Defect CasesPfizer knew about the link between Zoloft use during pregnancy and birth defects in newborn babies. However, they decided to ignore this crucial patient safety information. A lawyer in the first Zoloft birth defects lawsuit to go to trial shared this with the jury during closing arguments in a state court in St. Louis on April 17, 2015.

The lawyer pointed specifically to an internal document dating before 1991 that included the recommendation that women able to become pregnant shouldn’t use Zoloft due to birth defect risks.

Furthermore, the lawyer argued that, even with knowledge of Zoloft and birth defects risks, Pfizer made no move to issue a sufficient warning. Pfizer didn’t update Zoloft’s drug safety label; therefore, doctors and patients were left in the dark about the dangers of Zoloft use during pregnancy.

The lawyer represents the plaintiffs in the case, the Pesante family, whose son was born with heart defects after his mother consumed Zoloft during pregnancy.

The son’s heart defects required three open-heart surgeries. Only a month after being born, the boy received a pacemaker.

In a Bloomberg article about the Zoloft trial, the defendants argued in their closing statement that Pfizer did issue warnings, and that these warnings were approved by the U.S. Food and Drug Administration (FDA).

Now, it is up to the jury to decide if Pfizer did indeed issue a sufficient warning, or if the company should be held liable for the harm done to the Pesante family and their son.

We can help your family

Carey Danis & Lowe is a St. Louis law firm that currently represents families whose children have been harmed by Zoloft in the womb. Our defective drug lawyers work tirelessly to recover losses for our clients.

If you would like to discuss your case with us, we are available by phone at 800.721.2519; you can also reach us by completing a confidential personal injury claim form.

We offer free case evaluations, and can help you decide if filing a Zoloft lawsuit is the right decision for you and your family.